reported that MitoQ decreased the expression of M1 markers and increased the expression of M2 markers both in vivo and in vitro after intracerebral hemorrhage through inhibiting the ROS/NLRP3 inflammasome pathway. This evidence concerns the gene NLRP3 and intracerebral hemorrhage.